As a functional medicine practitioner, I use functional laboratory evaluations that help me understand the root of the cause of their health problems.
These evaluations explore and pinpoint underlying biochemical glitches contributing to illness and disease.
I work in close collaboration with some of the best laboratories in the UK and the world offering a wide range of state-of-the art, cutting-edge, functional diagnostic tests, genomic tests, and biochemical reports.
Please see below a non-exhaustive list of laboratory tests that I can order for you once we have discussed your individual clinical case during your first consultation.
END13 Menopause™ Saliva, Urine £270
END14 Menopause Plus™ Saliva, Urine £378
END10 Rhythm™ Saliva £182
END11 Rhythm Plus™ Saliva £235
END03 DHEA Level Saliva £53
END17 Male Hormones Plus™ Saliva £172
END12 One Day Progesterone/Oestradiol Saliva £80
END01 Adrenal Stress Profile Saliva £85
END02 Comprehensive Adrenal Stress Profile Saliva £107
END09 Melatonin Profile Saliva £77
END16 Testosterone Saliva £72
END41 One Day Hormone Check Saliva £275
END23 Complete Hormones™ FMV/24Hr Urine £433
END21 Essential Oestrogens FMV/24Hr Urine £265
END19 Oestrogen Metabolism Urine £145
END20 Oestrogen Metabolism Plus FMV/24Hr Urine £230
END25 Urine Iodine Urine £71
END08 Urine Thyroid Hormones (T3/T4) Urine £107
END26 Urine Thyroid Hormones (T3/T4) + Iodine Urine £151
END05 Adrenal - Thyroid Profile (24H) Urine £160
END18 Bone Resorption: Osteoporosis Risk Assessment Urine £100
0142 Estronex Profile Urine £173
0145 Estronex Profile with Bone Resorption Profile Urine £232
GEN01 CardioGenomicPlus™ Profile ~ Buccal Swab £330
GEN03 DetoxiGenomic® Profile ~ Buccal Swab £360
GEN04 EstroGenomic™ Profile ~ Buccal Swab £500
GEN05 ImmunoGenomic® Profile ~ Buccal Swab £235
GEN06 NeuroGenomic™ Profile ~ Buccal Swab £355
ADD-ON Add-On Apo-E (apolipoprotein E) for: DetoxiGenomic, ImmunoGenomic, and NeuroGenomic ~ Buccal Swab £100
2205 GI Effects® Microbial cEcology Stool Profile Stool £200
DIG01 CDSA (Comprehensive Digestive Stool Analysis)™ Stool £210
DIG02 CDSA/P (Comprehensive Digestive Stool Analysis/Parasitology)™ Stool £245
DIG03 CDSA 2.0 ™ w/o Parasitology (Comprehensive Digestive Stool Analysis 2.0)™ Stool £260
DIG04 CDSA/P 2.0™ (Comprehensive Digestive Stool Analysis 2.0/Parasitology)™ Stool £300
DIG05 Comprehensive Parasitology (CP) Stool £160
DIG06 Parasitology (P) Stool £108
DIG07 Microbiology Profile Stool £100
DIG08 Macroscopic Examination for Worms (CDSA, CDSA/P, CDSA 2.0, CDSA/P 2.0, CP, Parasitology) Stool £35
DIG09 Calprotectin Stool £65
DIG10 Gut Immunology Stool £168
DIG11 H. pylori Stool Test Stool £85
DIG12 Helicobacter Pylori Breath Test Breath £112
DIG15 IBStatus Stool £225
DIG16 Pancreatic Elastase Stool £105
Additional Add-On Markers for specific stool tests listed above (as specified by parentheses)
Campylobacter (GI Effects 2200, 2205) Stool £40
Clostridium difficile EIA (GI Effects 2200, 2205) Stool £55
Escherichia coli EIA (GI Effects 2200, 2205) Stool £40
Helicobacter pylori EIA (GI Effects 2200, 2205, IBStatus) Stool £90
Eosinophil Protein X (IBStatus) Stool £40
"AUTOIMMUNE DISORDERS are a growing concern. Cyrex is focused on the fast growing health issues of autoimmune disorders now affecting tens of millions of people in the United States alone. Our test panels are designed to evaluate your immune reactions using our proprietary, advanced technology. Below are the arrays we offer and their benefits to you, each categorized in the following order: Predictive Antibodies, Barrier Permeability and Reactivity Triggers." - Cyrex Labs
"We are a progressive, integrated team in the field of integrative, functional and nutritional medicine. We are always adapting to new research and modifying our services to meet the high standards we set ourselves. " - Invivo Clinical
"Meta-analyses showed that flavonoids have a promising role in improving visual function in patients with glaucoma and ocular hypertension (OHT), and appear to play a part in both improving and slowing the progression of visual field loss".
-Graefes Arch Clin Exp Ophthalmol. 2015 Sep 4. Epub 2015 Sep 4. PMID: 26340868
"Animal studies show that holy basil helps the body maintain homeostasis of the stress hormone cortisol.1 It rebalances mood-associated neurotransmitters in the brain—specifically ones that can produce feelings of hopelessness, which is a key component of stress-induced depression."2
1- Phytother Res. 2016;30(5):805-14
2-Indian J Med Res. 2012;135(4):548-54
"Lycopene, the predominant carotenoid in tomatoes and tomato-based foods, is reported to protect against various cancers, especially prostate cancer.
Cell growth was inhibited 20% at 0.2 microM lycopene and 40% at 50 microM lycopene after a 24-hr incubation. In the Comet assay, lycopene-treated cells showed less DNA damage than did placebo-treated cells. The inhibition of Hep3B cell growth in this study demonstrates the antitumor properties of lycopene."
- Biofactors. 2005 ;23(3):129-39. PMID: 16410635
"Accumulating evidence indicates that abdominal adiposity is positively related to cardiovascular disease (CVD) risk and some other diseases independently of overall adiposity. However, the association of premature death resulting from these diseases with abdominal adiposity has not been widely studied, and findings are inconsistent. In a prospective cohort study of 44,636 women in the Nurses' Health Study, associations of abdominal adiposity with all-cause and cause-specific mortality were examined. During 16 years of follow-up, 3507 deaths were identified, including 751 cardiovascular deaths and 1748 cancer deaths. After adjustment for body mass index and potential confounders, the relative risks across the lowest to the highest waist circumference quintiles were 1.00, 1.11, 1.17, 1.31, and 1.79 (95% confidence interval [CI], 1.47 to 1.98) for all-cause mortality; 1.00, 1.04, 1.04, 1.28, and 1.99 (95% CI, 1.44 to 2.73) for CVD mortality; and 1.00, 1.18, 1.20, 1.34, and 1.63 (95% CI, 1.32 to 2.01) for cancer mortality (all P<0.001 for trend). Among normal-weight women (body mass index, 18.5 to<25 kg/m(2)), abdominal obesity was significantly associated with elevated CVD mortality: Relative risk associated with waist circumference>or = 88 cm was 3.02 (95% CI, 1.31 to 6.99) and for waist-to-hip ratio>0.88 was 3.45 (95% CI, 2.02 to 6.92). After adjustment for waist circumference, hip circumference was significantly and inversely associated with CVD mortality."
-Circulation. 2008 Apr 1;117(13):1658-67. doi: 10.1161/CIRCULATIONAHA.107.739714. Epub 2008 Mar 24.
"Major changes in self-reported eating behaviors included eating only when experiencing true physiological hunger and stopping when sensing a feeling of fullness. Self-efficacy for these behaviors was reported to be enhanced by observing weight loss for themselves or others. Support from other group members, the simplicity of the program, and spiritual benefits through prayer and scripture reading were also reported to enhance confidence. Women indicated that they relied on an internal locus of control based on a sense of self-discipline.
CONCLUSIONS AND IMPLICATIONS:
Traditional means to enhance self-efficacy were important for all women; however, for some women, spirituality was also an important aspect of adhering to program principles."
- J Nutr Educ Behav. 2004 Jan-Feb;36(1):13-5.